Development of the Danish Prospective Sarcoidosis Registry and Baseline Characteristics of a Danish Sarcoidosis Cohort

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04388566

Enrollment

150

Registered

2020-05-14

Start date

2019-12-01

Completion date

2022-02-28

Last updated

2022-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoidosis

Brief summary

Development of a Danish Sarcoidosis Registry. Characterization of a cohort of sarcoidosis patients with respect to the baseline epidemiological characteristics, comorbidities, radiology, histopathology, diagnostic investigations and treatment.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of sarcoidosis * Signed informed consent

Exclusion criteria

* Inability or unwillingness to adhere to the study * Inability to give informed consent

Design outcomes

Primary

Measure	Time frame	Description
Characterization of Danish sarcoid patients	2 years	Epidemiology and Baseline characteristics of a Danish Sarcoidosis Cohort
Feasibility and completion of a Sarcoidosis Registry.	2 years	Development of a Danish sarcoidosis registry Data on epidemiology, clinical characteristics, diagnosis and management will be registered

Countries

Denmark

Outcome results